ALSA Ventures — Full Portfolio

Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome.

BiotechHealthtechLeuven, BE

Federico Grossi(Clinical Advisor & Acting CMO)

Co-investorsDRDroia VenturesPFPfizer VenturesVIVIBPFPfizer Venture Investments

Axovia Therapeutics develops AAV9-based gene therapies for ciliopathies, a group of rare inherited genetic diseases, with a lead program targeting Bardet-Biedl Syndrome (BBS1) to prevent blindness and reverse obesity.

BiotechDeep TechHealthtech

PBPhil Beales(Co-founder)inVHVictor Hernandez(Co-founder & Chief Scientific Officer)in

Co-investorsALAlbionVC

Mailchimp is an email and SMS marketing platform that helps businesses of all sizes automate customer communications and drive revenue through AI-powered analytics and campaign tools.

E-commerceMarketing TechSaaS

Co-investors2424 HaymarketDEDecisive PointFIFifth WallFIFitz Gate VenturesFOForma PrimeHEHello Tomorrow+10 more

Epsilogen develops antibody therapeutics based on the IgE, IgA, and IgG immunoglobulin isotypes for the treatment of cancer, matching each isotype to specific tumor types and combining isotypes into single antibody molecules.

BiotechHealthtech

TWTim Wilson(Chief Executive Officer)Kevin FitzGerald(Chief Scientific Officer)inCristina Oliva(Chief Medical Officer)inNRNick Robbins-Cherry(Chief Financial Officer)inElizabeth Hardaker(Chief Translational Science Officer)

Co-investors3B3B Future Health FundALAlbionVCEPEpidarex CapitalGLGlobal BioAccess FundNONovartis Venture FundUCUCL Technology Fund+1 more

Jatri is a global B2B travel commerce platform that digitizes transport operators and travel buyers through a unified technology and finance ecosystem.

B2B MarketplacesConsumerLogistics & Supply ChainMobility & TransportationSaaSTravel & HospitalityDhaka, BD

Aziz Arman(Founder & CEO)in

Co-investorsDODoha Tech AngelsGOGobi PartnersLOLoftyInc CapitalREReflect VenturesSPSprint VcBRBrain-Too-Free Ventures+3 more

Oxford BioTherapeutics is a clinical-stage oncology company developing antibody-based therapies for cancer treatment.

BiotechHealthtechMedical DevicesOxford, GB

Co-investorsCACalculus Capital Ltd.OXOxfordPEPercipient CapitalPEPerscitus LLP

Presage Biosciences is a translational oncology company that operates the CIVO (Comparative In Vivo Oncology) platform, a patented intratumoral drug delivery and analysis technology for evaluating how tumors respond to multiple investigational treatments.

BiotechDeep TechHealthtech

Promatix develops bispecific antibody drug conjugates (ADCs) for solid tumours, using a proteomics-based platform to identify cancer surface marker pairs for cis-bispecific targeting.

AI & Machine LearningBiotechDeep Tech

BoardGMGraeme Martin(Executive Chairman)in

ReproNovo develops therapeutic solutions for male and female fertility and women's health conditions like adenomyosis, targeting unmet medical needs in reproductive medicine.

BiotechFemTechHealthtechMedical DevicesLausanne, CH

Co-investorsJEJeito CapitalM M VenturesYSYsios Capital

Co-investorsADAdBio partnersGLGlobal Health Investment CorporationINIn-Q-Tel

Vantage Biosciences develops clinical-stage drug therapies for retinal and other diseases, with a focus on the AOC3 target and its role in liver and eye disease.

BiotechHealthtechMedical Devices

BoardASAlek Safarian(Founder)in